Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 15:10:323.
doi: 10.3389/fnagi.2018.00323. eCollection 2018.

Complementary and Alternative Medicine for Idiopathic Parkinson's Disease: An Evidence-Based Clinical Practice Guideline

Ki-Ho Cho  1 , Tae-Hun Kim  2 , Seungwon Kwon  1 , Woo-Sang Jung  1 , Sang-Kwan Moon  1 , Chang-Nam Ko  1   3 , Seung-Yeon Cho  1   3 , Chan-Yong Jeon  4 , Sang-Ho Lee  5 , Tae Young Choi  6 , Ji Hee Jun  6 , Jiae Choi  7 , Myeong Soo Lee  6 , Eun Kyoung Chung  8
Affiliations

Complementary and Alternative Medicine for Idiopathic Parkinson's Disease: An Evidence-Based Clinical Practice Guideline

Ki-Ho Cho et al. Front Aging Neurosci. .

Abstract

Patients with idiopathic Parkinson's disease (IPD) require long-term care and are reported to use complementary and alternative medicine (CAM) interventions frequently. This CAM-specific clinical practice guideline (CPG) makes recommendations for the use of CAM, including herbal medicines, acupuncture, moxibustion, pharmaco-acupuncture, and qigong (with Tai chi) in patients with IPD. This guideline was developed using an evidence-based approach with randomized controlled trials currently available. Even though this CPG had some limitations, mainly originating from the bias inherent in the research on which it is based, it would be helpful when assessing the value of the CAM interventions frequently used in patients with IPD.

Keywords: clinical practice guideline; complementary and alternative medicine; evidence-based medicine; idiopathic Parkinson’s disease; recommendations.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
The clinical practice guideline development process.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bastide M. F., Meissner W. G., Picconi B., Fasano S., Fernagut P.-O., Feyder M., et al. (2015). Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson’s disease. Prog. Neurobiol. 132 96–168. 10.1016/j.pneurobio.2015.07.002 - DOI - PubMed
    1. Clarke T. C., Black L. I., Stussman B. J., Barnes P. M., Nahin R. L. (2015). Trends in the use of complementary health approaches among adults: United States, 2002–2012. Natl. Health Stat. Rep. 101–16. - PMC - PubMed
    1. Grimes D., Gordon J., Snelgrove B., Lim-Carter I., Fon E., Martin W., et al. (2012). Canadian guidelines on Parkinson’s Disease. Can. J. Neurol. Sci. 39:S1 10.1017/S031716710001516X - DOI - PubMed
    1. Guyatt G. H., Oxman A. D., Vist G. E., Kunz R., Falck-Ytter Y., Alonso-Coello P., et al. (2008). GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 924–926. 10.1136/bmj.39489.470347.AD - DOI - PMC - PubMed
    1. Kim S. R., Lee T. Y., Kim M. S., Lee M. C., Chung S. J. (2009). Use of complementary and alternative medicine by Korean patients with Parkinson’s disease. Clin. Neurol. Neurosurg. 111 156–160. 10.1016/j.clineuro.2008.09.011 - DOI - PubMed

LinkOut - more resources